Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) Operating Income (2023 - 2025)

Incannex Healthcare (IXHL) has disclosed Operating Income for 3 consecutive years, with -$7.0 million as the latest value for Q4 2025.

  • Quarterly Operating Income fell 39.79% to -$7.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$26.3 million through Dec 2025, up 7.38% year-over-year, with the annual reading at -$23.8 million for FY2025, 20.81% up from the prior year.
  • Operating Income hit -$7.0 million in Q4 2025 for Incannex Healthcare, down from -$6.8 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of -$4.9 million in Q3 2023 to a low of -$9.7 million in Q2 2024.
  • Historically, Operating Income has averaged -$6.8 million across 3 years, with a median of -$6.9 million in 2025.
  • Biggest five-year swings in Operating Income: soared 37.32% in 2024 and later plummeted 39.79% in 2025.
  • Year by year, Operating Income stood at -$8.0 million in 2023, then skyrocketed by 37.32% to -$5.0 million in 2024, then crashed by 39.79% to -$7.0 million in 2025.
  • Business Quant data shows Operating Income for IXHL at -$7.0 million in Q4 2025, -$6.8 million in Q3 2025, and -$7.5 million in Q2 2025.